| Followers | 45 |
| Posts | 129 |
| Boards Moderated | 0 |
| Alias Born | 03/02/2021 |
Tuesday, January 14, 2025 10:37:11 AM
As Flipper and others pointed out, the quotes you cited are not even close to representative of what most companies are doing.
Heck, the quotes from Nymox are not even representative of what Nymox is doing. Sure, in July of 2024 they included one line in one PR in which they promised to "update later in the cycle when appropriate." In the six months since then, they have provided no additional information.
As for Telix, they are by far the exception when it comes to communication, even (as Lykiri pointed out yesterday) going so far as to claim they know they will receive approval this month. Who knows why they behave differently than (quite literally) every other company? Perhaps it's because they're Australian, a nation of outlaws (it's my birthplace so I can say that).
At any rate, there is nothing in the evidence to support statements like: "wild," "unfair," "NWBO has to play by different rules than other companies," "liar and/or moron," "lying sack of sh*t," and so on.
Believe it or not, NWBO has been consistent with the vast majority of other companies when it comes to communications around this process (if not even somewhat more communicative). And their progress through the process has been consistent with MHRA's recent performance (if not even slightly more expeditious). That is what the evidence supports.
Heck, the quotes from Nymox are not even representative of what Nymox is doing. Sure, in July of 2024 they included one line in one PR in which they promised to "update later in the cycle when appropriate." In the six months since then, they have provided no additional information.
As for Telix, they are by far the exception when it comes to communication, even (as Lykiri pointed out yesterday) going so far as to claim they know they will receive approval this month. Who knows why they behave differently than (quite literally) every other company? Perhaps it's because they're Australian, a nation of outlaws (it's my birthplace so I can say that).
At any rate, there is nothing in the evidence to support statements like: "wild," "unfair," "NWBO has to play by different rules than other companies," "liar and/or moron," "lying sack of sh*t," and so on.
Believe it or not, NWBO has been consistent with the vast majority of other companies when it comes to communications around this process (if not even somewhat more communicative). And their progress through the process has been consistent with MHRA's recent performance (if not even slightly more expeditious). That is what the evidence supports.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
